Adagio Medical Holdings, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 |
|---|---|---|---|
| Revenue | $0 | — | $300,000 |
| Operating income | -$21.9M | — | -$27.9M |
| Cost of revenue | $684,000 | — | $1.3M |
| Cash from operations | -$19.0M | — | -$25.7M |
| Capital expenditure | $374,000 | — | $333,000 |
| Free cash flow | -$19.4M | — | -$26.0M |
| Impairments | $0 | — | $0 |
| Total assets | $43.3M | $48.4M | $6.8M |
| Total liabilities | $30.9M | $28.5M | $47.4M |
Shares outstanding 22.2M · Free float 22.6%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.